Insight Guide
What’s Next for mRNA?
Now that the pharma industry and regulators have significant data on safety and efficacy of mRNA vaccines, many companies are looking beyond infectious disease to potentially develop therapies for a variety of indications. In this Q&A, a Catalent Biologics expert addresses the challenges of mRNA development and manufacturing, potential solutions & the future of mRNA in industry.
